64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)
Clinical trial NCT05407311 · COMPLETED
Trial details
- NCT number
- NCT05407311
- Sponsor
- Clarity Pharmaceuticals Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-19
- Primary completion
- 2024-05-13
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.